The international healthcare manufacturing sector is experiencing an unprecedented shift toward higher safety standards, driven by the emergence of ultra-potent drug compounds. As modern pharmaceutical formulations lean heavily into highly targeted treatments, oncology medications, and delicate biologics, the risk of operator exposure and cross-contamination has escalated significantly....
Bangla